Patient-level discordance in population percentiles of the total cholesterol to high-density lipoprotein cholesterol ratio in comparison with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol: The very large database of lipids study (VLDL-2B)

Circulation

Volumn 132, Issue 8, 2015, Pages 667-676

  Elshazly, Mohamed B ^a,b   Quispe, Renato ^a   Michos, Erin D ^a,c   Sniderman, Allan D ^d   Toth, Peter P ^a,e,f   Banach, Maciej ^g   Kulkarni, Krishnaji R ^h   Coresh, Josef ^c   Blumenthal, Roger S ^a   Jones, Steven R ^a   Martin, Seth S ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e CGH MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h Atherotech Diagnostics Inc   (United States)

Author keywords

cholesterol; lipids; lipoproteins; primary prevention

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; ULTRACENTRIFUGATION; BLOOD; CLINICAL TRIAL; FACTUAL DATABASE; HEALTH SURVEY; MIDDLE AGED; NUTRITION; STATISTICS AND NUMERICAL DATA;

AGED; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; NUTRITION SURVEYS; POPULATION SURVEILLANCE;

EID: 84940704745     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.016163     Document Type: Article

References (39)

1. National Ambulatory Medical Care Survey: 2009 Summary Tables. http://www.cdc.gov/nchs/data/ahcd/namcs-summary/2009-namcs-web-tables.pdf. Published December 2009. Accessed February 2, 2015
2. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, American Heart Association Strategic Planning Task Force and Statistics Committee Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010 12 586 613
3. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 25 suppl 2 S1 45. doi: 10.1161/01.cir.0000437738.63853.7a
4. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hobbs R, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Reviewers D, Funck-Brentano C, Poldermans D, Berkenboom G, de Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL., ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011 32 1769 1818
5. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini GB, McPherson R, Francis GA, Poirier P, Lau DC, Grover S, Genest J Jr, Carpentier AC, Dufour R, Gupta M, Ward R, Leiter LA, Lonn E, Ng DS, Pearson GJ, Yates GM, Stone JA, Ur E., 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol 2013 29 151 167. doi: 10.1016/j.cjca.2012.11.032
6. Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV., National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1-executive summary. J Clin Lipidol 2014 8 473 488. doi: 10.1016/j.jacl.2014.07.007
7. Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, Cuevas A, Davidson MH, Genest J, Kesäniemi YA, Sadikot S, Santos RD, Susekov AV, Sy RG, LaleTokgözoglu S, Watts GF, Zhao D., An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia-full report. J Clin Lipidol 2014 8 29 60
8. Friedewald WT, Levy RI, Fredrickson DS., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 499 502
9. Martin SS, Khokhar AA, May HT, Kulkarni KR, Blaha MJ, Joshi PH, Toth PP, Muhlestein JB, Anderson JL, Knight S, Li Y, Spertus JA, Jones SR, Lipoprotein Investigators Collaborative (LIC) HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative. Eur Heart J 2015 36 22 30. doi: 10.1093/eurheartj/ehu264
10. Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J., Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014 371 203 212
11. Toth PP, Barylski M, Nikolic D, Rizzo M, Montalto G, Banach M., Should low high-density lipoprotein cholesterol (HDL-C) be treated? Best Pract Res Clin Endocrinol Metab 2014 28 353 368. doi: 10.1016/j.beem.2013.11.002
12. Mathews SC, Mallidi J, Kulkarni K, Toth PP, Jones SR., Achieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based data. PLoS One 2012 7 e33692. doi: 10.1371/journal.pone.0033692
13. Castelli WP., Cholesterol and lipids in the risk of coronary artery disease-The Framingham Heart Study. Can J Cardiol 1988 4(suppl A) 5A 10A
14. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S, INTERHEART study investigators Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008 372 224 233. doi: 10.1016/S0140-6736(08)61076-4
15. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE., Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005 294 326 333. doi: 10.1001/jama.294.3.326
16. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM., Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009 119 931 939. doi: 10.1161/CIRCULATIONAHA.108.816181
17. Elshazly MB, Martin SS, Blaha MJ, Joshi PH, Toth PP, McEvoy JW, Al-Hijji MA, Kulkarni KR, Kwiterovich PO, Blumenthal RS, Jones SR., Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL-2 study (very large database of lipids). J Am Coll Cardiol 2013 62 1960 1965. doi: 10.1016/j.jacc.2013.07.045
18. Martin SS, Blaha MJ, Toth PP, Joshi PH, McEvoy JW, Ahmed HM, Elshazly MB, Swiger KJ, Michos ED, Kwiterovich PO, Kulkarni KR, Chimera J, Cannon CP, Blumenthal RS, Jones SR., Very large database of lipids: rationale and design. Clin Cardiol 2013 36 641 648. doi: 10.1002/clc.22214
19. Kulkarni KR., Cholesterol profile measurement by vertical auto profile method. Clin Lab Med 2006 26 787 802. doi: 10.1016/j.cll.2006.07.004
20. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR., Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013 310 2061 2068. doi: 10.1001/jama.2013.280532
21. Martin SS, Michos ED., Are we moving towards concordance on the principle that lipid discordance matters? Circulation 2014 129 539 541. doi: 10.1161/CIRCULATIONAHA.113.007207
22. Sniderman AD, Lamarche B, Contois JH, de Graaf J., Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB. Curr Opin Lipidol 2014 25 461 467. doi: 10.1097/MOL.0000000000000127
23. Sniderman AD, Islam S, Yusuf S, McQueen MJ., Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study. Atherosclerosis 2012 225 444 449. doi: 10.1016/j.atherosclerosis.2012.08.039
24. Mora S, Buring JE, Ridker PM., Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation 2014 129 553 561. doi: 10.1161/CIRCULATIONAHA.113.005873
25. Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr, Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol 2011 5 105 113. doi: 10.1016/j.jacl.2011.02.001
26. Ahmed H, Elshazly M, Martin S, Blaha M, Kulkarni K, Jones S., Ratio of dense to buoyant LDL subclass is associated with LDL density phenotype (VLDL-5). Open Chem Biomed Methods J 2013 6 1 5
27. Vodnala D, Bard RL, Krishnan SM, Jackson EA, Rubenfire M, Brook RD., Potential effects on clinical management of treatment algorithms on the basis of apolipoprotein-B/A-1 and total/high-density lipoprotein-cholesterol ratios. J Clin Lipidol 2011 5 159 165. doi: 10.1016/j.jacl.2011.02.004
28. Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM., Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006 259 247 258. doi: 10.1111/j.1365-2796.2006.01616.x
29. Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, Wilson PW, D'Agostino RB., LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study: implications for LDL management. J Clin Lipidol 2007 1 583 592. doi: 10.1016/j.jacl.2007.10.001
30. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G., Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003 139 802 809
31. Pencina MJ, D'Agostino RB, Zdrojewski T, Williams K, Thanassoulis G, Furberg CD, Peterson ED, Vasan RS, Sniderman AD., Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. Eur J Prev Cardiol. [published online ahead of print January 29, 2015] doi: 10.1177/2047487315569411. http://cpr/sagepub.com. Accessed February 24, 2015
32. Gardner CD, Fortmann SP, Krauss RM., Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996 276 875 881
33. Mora S., Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. Circulation 2009 119 2396 2404. doi: 10.1161/CIRCULATIONAHA.108.819359
34. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, TNT Study Group; IDEAL Study Group Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008 117 3002 3009. doi: 10.1161/CIRCULATIONAHA.107.713438
35. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS., Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007 298 776 785. doi: 10.1001/jama.298.7.776
36. Manickam P, Rathod A, Panaich S, Hari P, Veeranna V, Badheka A, Jacob S, Afonso L., Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage? J Clin Lipidol 2011 5 82 90. doi: 10.1016/j.jacl.2010.12.001
37. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH., A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991 325 373 381. doi: 10.1056/NEJM199108083250601
38. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R., Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-Analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007 370 1829 1839
39. Degoma EM, Davis MD, Dunbar RL, Mohler ER 3rd, Greenland P, French B., Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2013 229 517 523. doi: 10.1016/j.atherosclerosis.2013.03.012